Objective To assess mood stabilizer (MS) and second-generation antipsychotic (SGA)
prescribing trends in bipolar disorder (BD) outpatients referred to a bipolar disorder specialty …

Objective: Pharmacological options for treating bipolar disorder have increased over the
past 20 years, with several second-generation antipsychotics receiving regulatory approval …

Background The study compared treatment failure when using three therapeutic strategies
in bipolar disorders:(i) mood stabilizers (MSs: lithium, valpromide, divalproate …

The increasing number of pharmacological treatment options for bipolar disorder seems to
be paralleled by the number of evidence-based guidelines published previously. The aim of …

Background: The potential benefits of typical antipsychotic agents in bipolar disorder are
offset by serious treatment-associated side effects. Despite these concerns and the …

Management of bipolar disorder (BPD) may require multiple medications, including lithium,
anticonvulsants, and antipsychotics (both conventional and atypical). Updated treatment …

Relatively absent from previous studies of the pharmacotherapy for bipolar disorder is
examination of the impact of comorbidity on treatment choices. This has occurred despite the …

OBJECTIVE: This study examined recent changes in the prescribing patterns for
medications to treat bipolar disorder in office-based psychiatric practice. METHOD: The …

Introduction Bipolar disorder is a chronic and complex disorder that can be difficult to treat.
The objective of this retrospective study was to describe treatment patterns among patients …

Objective There is limited information available on the prescription of psychotropic agents to
patients with bipolar I (BD-I) and bipolar II disorder (BD-II). The purpose of this study was to …